Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes

References

• Bilgir O, Kebapcilar L, Bilgir F, et al. (2010). Decreased serum fetuin-A levels are associated with coronary artery diseases. Intern Med 49:1281–5
   PubMed Web of Science ®Google Scholar
• Chen L, Magliano DJ, Zimmet PZ. (2011). The worldwide epidemiology of type 2 diabetes mellitus–present and future perspectives. Nat Rev Endocrinol 8:228–36
   PubMed Web of Science ®Google Scholar
• Cohn PF, Fox KM, Daly C. (2003). Silent myocardial ischemia. Circulation 108:1263–77
   PubMed Web of Science ®Google Scholar
• Gejyo F, Schmid K. (1981). Purification and characterization of the two forms of human plasma alpha 2HS-glycoprotein. Biochim Biophys Acta 671:78–84
   PubMedGoogle Scholar
• Haffner SM, Lehto S, Rönnemaa T, et al. (1998). Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 339:229–34
   PubMed Web of Science ®Google Scholar
• Ix JH, Barrett-Connor E, Wassel CL, et al. (2011). The associations of fetuin-A with subclinical cardiovascular disease in community-dwelling persons: the Rancho Bernardo Study. J Am Coll Cardiol 58:2372–9
   Google Scholar
• Ix JH, Katz R, de Boer IH, et al. (2012). Fetuin-A is inversely associated with coronary artery calcification in community-living persons: the Multi-Ethnic Study of Atherosclerosis. Clin Chem 58:887–95
   Google Scholar
• Ix JH, Shlipak MG, Brandenburg VM, et al. (2006). Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation 113:1760–7
   PubMed Web of Science ®Google Scholar
• Laughlin GA, Cummins KM, Wassel CL, et al. (2012). The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study. J Am Coll Cardiol 59:1688–96
   Google Scholar
• Li W, Zhu S, Li J, et al. (2011). A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation. PLoS One 6:e16945
   PubMed Web of Science ®Google Scholar
• Lim P, Collet JP, Moutereau S, et al. (2007). Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction. Clin Chem 53:1835–40
   PubMed Web of Science ®Google Scholar
• Mathews ST, Singh GP, Ranalletta M, et al. (2002). Improved insulin sensitivity and resistance to weight gain in mice null for the Ahsg gene. Diabetes 51:2450–8
   PubMed Web of Science ®Google Scholar
• Mori K, Emoto M, Araki T, et al. (2007). Association of serum fetuin-A with carotid arterial stiffness. Clin Endocrinol (Oxf) 66:246–50
   PubMed Web of Science ®Google Scholar
• Mori K, Ikari Y, Jono S, et al. (2010). Fetuin-A is associated with calcified coronary artery disease. Coron Artery Dis 21:281–5
   Google Scholar
• Reinehr T, Roth CL. (2008). Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss. J Clin Endocrinol Metab 93:4479–85
   PubMed Web of Science ®Google Scholar
• Rittig K, Thamer C, Haupt A, et al. (2009). High plasma fetuin-A is associated with increased carotid intima-media thickness in a middle-aged population. Atherosclerosis 207:341–2
   PubMed Web of Science ®Google Scholar
• Shang FJ, Wang JP, Liu XT, et al. (2011). Serum omentin-1 levels are inversely associated with the presence and severity of coronary artery disease in patients with metabolic syndrome. Biomarkers 16:657–62
   PubMed Web of Science ®Google Scholar
• Stalenhoef AF, Davidson MH, Robinson JG, et al. (2012). Efficacy and safety of dalcetrapib in type 2 diabetes mellitus and/or metabolic syndrome patients, at high cardiovascular disease. Diabetes Obes Metab 14:30–9
   PubMed Web of Science ®Google Scholar
• Stefan N, Fritsche A, Weikert C, et al. (2008). Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 57:2762–7
   PubMed Web of Science ®Google Scholar
• Stefan N, Hennige AM, Staiger H, et al. (2006). Alpha2-Heremans–Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans. Diabetes Care 29:853–7
   PubMed Web of Science ®Google Scholar
• Tatami R, Mabuchi H, Ueda K, et al. (1981). Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease. Circulation 64:1174–84
   PubMed Web of Science ®Google Scholar
• Vörös K, Gráf L Jr, Prohászka Z, et al. (2011). Serum fetuin-A in metabolic and inflammatory pathways in patients with myocardial infarction. Eur J Clin Invest 41:703–9
   PubMed Web of Science ®Google Scholar
• Weikert C, Stefan N, Schulze MB, et al. (2008). Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 118:2555–62
   PubMed Web of Science ®Google Scholar